Clinical trial
A Randomized Controlled Trial to Determine the Efficacy of Local Antibiotic Delivery in the Prevention of Breast Tissue Expander-Associated Infections
NCT07220967 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial to Determine the Efficacy of Local Antibiotic Delivery in the Prevention of Breast Tissue Expander-Associated Infections
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 21, 2025
- Completion date
- October 31, 2027
- Enrollment
- 392 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer